Somatostatin Antibodies

Santa Cruz Biotechnology provides a broad selection of Somatostatin monoclonal antibodies for research focused on understanding somatostatin's role in various physiological processes. Somatostatin Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Somatostatin is a peptide hormone that plays a critical role in inhibiting the release of several other hormones, including growth hormone and insulin, thereby regulating various bodily functions. Its importance extends to the modulation of neurotransmission and the regulation of gastrointestinal activity, making it a key player in maintaining homeostasis. Research on somatostatin has implications in understanding disorders such as acromegaly, diabetes, and certain types of cancer. Somatostatin research continues to reveal new insights into hormone regulation and cellular signaling pathways. Understanding somatostatin's mechanisms can lead to improved therapeutic strategies for hormone-related disorders. Ongoing studies of somatostatin's effects on different tissue types help advance knowledge of endocrine system regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of somatostatin's role in health and disease.